| Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study F Passamonti, C Cattaneo, L Arcaini, R Bruna, M Cavo, F Merli, ... The Lancet Haematology 7 (10), e737-e745, 2020 | 546 | 2020 |
| Loss of the tumor suppressor PML in human cancers of multiple histologic origins C Gurrieri, P Capodieci, R Bernardi, PP Scaglioni, K Nafa, LJ Rush, ... Journal of the National Cancer Institute 96 (4), 269-279, 2004 | 427 | 2004 |
| Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis C Agostini, C Gurrieri Proceedings of the American Thoracic Society 3 (4), 357-363, 2006 | 260 | 2006 |
| The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis L Trentin, C Agostini, M Facco, F Piazza, A Perin, M Siviero, C Gurrieri, ... The Journal of clinical investigation 104 (1), 115-121, 1999 | 203 | 1999 |
| Mzf1 controls cell proliferation and tumorigenesis M Gaboli, PA Kotsi, C Gurrieri, G Cattoretti, S Ronchetti, C Cordon-Cardo, ... Genes & development 15 (13), 1625-1630, 2001 | 153 | 2001 |
| Multiple myeloma cell survival relies on high activity of protein kinase CK2 FA Piazza, M Ruzzene, C Gurrieri, B Montini, L Bonanni, G Chioetto, ... Blood 108 (5), 1698-1707, 2006 | 147 | 2006 |
| The theory of APL F Piazza, C Gurrieri, PP Pandolfi Oncogene 20 (49), 7216-7222, 2001 | 136 | 2001 |
| Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways F Piazza, S Manni, M Ruzzene, LA Pinna, C Gurrieri, G Semenzato Leukemia 26 (6), 1174-1179, 2012 | 129 | 2012 |
| Chronic Lymphocytic Leukemia B Cells Can Undergo Somatic Hypermutation and Intraclonal Immunoglobulin VHDJH Gene Diversification C Gurrieri, P McGuire, H Zan, XJ Yan, A Cerutti, E Albesiano, SL Allen, ... The Journal of experimental medicine 196 (5), 629-639, 2002 | 115 | 2002 |
| Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of … S Manni, A Brancalion, E Mandato, LQ Tubi, A Colpo, M Pizzi, ... PloS one 8 (9), e75280, 2013 | 94 | 2013 |
| Protein kinase CK2 protects multiple myeloma cells from ER stress–induced apoptosis and from the cytotoxic effect of hsp90 inhibition through regulation of the unfolded protein … S Manni, A Brancalion, LQ Tubi, A Colpo, L Pavan, A Cabrelle, E Ave, ... Clinical cancer research 18 (7), 1888-1900, 2012 | 84 | 2012 |
| Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia C Gurrieri, K Nafa, T Merghoub, R Bernardi, P Capodieci, A Biondi, ... Blood 103 (6), 2358-2362, 2004 | 83 | 2004 |
| Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis M Facco, I Baesso, M Miorin, M Bortoli, A Cabrelle, E Boscaro, C Gurrieri, ... Journal of Leucocyte Biology 82 (4), 946-955, 2007 | 65 | 2007 |
| Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival … L Quotti Tubi, C Gurrieri, A Brancalion, L Bonaldi, R Bertorelle, S Manni, ... Journal of hematology & oncology 6, 1-15, 2013 | 61 | 2013 |
| Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia L Quotti Tubi, S Canovas Nunes, A Brancalion, E Doriguzzi Breatta, ... Leukemia 31 (2), 292-300, 2017 | 58 | 2017 |
| Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death F Piazza, S Manni, LQ Tubi, B Montini, L Pavan, A Colpo, M Gnoato, ... BMC cancer 10, 1-14, 2010 | 52 | 2010 |
| 3-(2, 4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2, 5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of … C Gurrieri, F Piazza, M Gnoato, B Montini, L Biasutto, C Gattazzo, ... Journal of Pharmacology and Experimental Therapeutics 332 (3), 785-794, 2010 | 49 | 2010 |
| Cytokines, chemokines and other biomolecular markers in sarcoidosis. C Gurrieri, M Bortoli, E Brunetta, F Piazza, C Agostini Sarcoidosis, Vasculitis, and Diffuse Lung Diseases: Official Journal of …, 2005 | 45 | 2005 |
| Towards a new age in the treatment of multiple myeloma FA Piazza, C Gurrieri, L Trentin, G Semenzato Annals of hematology 86, 159-172, 2007 | 44 | 2007 |
| CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian … F Guolo, L Fianchi, P Minetto, M Clavio, M Gottardi, S Galimberti, ... Blood Cancer Journal 10 (10), 96, 2020 | 36 | 2020 |
